Back Other Health News Other Liver Disease Steatosis/NAFLD/NASH AASLD 2017: Women with Fatty Liver Disease at Higher Risk for Heart Disease

Other Infections

AASLD 2017: Women with Fatty Liver Disease at Higher Risk for Heart Disease


Women with non-alcoholic fatty liver disease (NAFLD) had a higher risk of cardiovascular events including chest pain and heart failure compared to women without the condition -- and about the same risk as men with NAFLD -- in a study presented at the 2017 AASLD Liver Meeting in October in Washington, DC.

The researchers calculated that a 50-year-old woman with fatty liver disease had about the same cardiovascular risk as a 53-year-old man with NAFLD, a 58-year-old man without NAFLD, or a 67-year-old woman without NAFLD.

These findings show that the normal protective effect of female sex on cardiovascular risk is lost in women with fatty liver disease, Alina Allen of the Mayo Clinic said at an AASLD press conference.

Non-alcoholic fatty liver diseaseand its more severe form, NASH, refer to the build-up of fat in the liver in people who do not drink heavily. Fatty liver disease, which is often associated with obesity and metabolic syndrome, is now the most common chronic liver disease worldwide. Over time, fat accumulation in the liver and the accompanying inflammation and build-up of scar tissue (fibrosis and cirrhosis) can interfere with normal liver function and lead to liver cancer.

Fatty liver disease is also associated with a higher risk of cardiovascular events -- and in fact people with NAFLD are more likely to die of heart disease than of liver disease.

Allen and colleagues conducted a study to assess the cardiovascular risk among women with NAFLD. Women in the general population have about a 20% lower risk of cardiovascular events than men and experience heart attacks about 5 years later, according to Allen, but it is not known whether this is the case for people with fatty liver disease.

The researchers evaluated a community cohort of adults diagnosed with NAFLD in Minnesota between 1997 and 2014. Each of the 3869 individuals with fatty liver disease was matched with multiple people of the same age and sex in the general population in the same community, for a total of 15,209 control subjects.

About half of the study participants were women and the median age was approximately 53 years. Women and men with NAFLD had more cardiovascular risk factors at baseline than the general population group, including higher body mass index and higher rates of pre-existing heart disease, diabetes, and high blood pressure.

Over a follow-up period of up to about 20 years, the researchers looked at new cardiovascular events including angina (chest pain), myocardial infarction (heart attack), heart failure, stroke, and atrial fibrillation (a type of irregular heartbeat), comparing their likelihood among NAFLD patients and the general population group.

At the time of NAFLD diagnosis, women and men with fatty liver disease were about equally likely to have a history of chest pain, heart failure, and stroke. These rates were higher than those for either women or men without NAFLD. Men with NAFLD had more heart attacks and atrial fibrillation than women with NAFLD, but among both men and women with NAFLD, these rates were higher than those for the same sex in the general population.

Women in the general population had a lower likelihood than men of experiencing new cardiovascular events during follow-up. Among people with NAFLD, however, incidence rates for women and men were comparable. Similarly, women and men with NAFLD were about equally likely to develop diabetes or high blood pressure if they did not already have it, and they were more likely to do so than people of either sex without NAFLD.

Within the general population, being female decreased the risk of cardiovascular events by 23%, or by 26% after controlling for various cardiovascular risk factors. For women and men with NAFLD, the likelihood was close to equal. But despite the similarity in their rates of cardiovascular events, women with NAFLD had a higher survival rate than men with NAFLD.

"We noted that in subjects with NAFLD, the risk for these events was higher in women than in men, contrary to those without the liver disease," Allen said in an AASLD press release. "In NAFLD, the protective effect of the female sex on cardiovascular risk disappears. Additionally, we noted cardiovascular events started at an earlier age for these women than in the general population."

Based on these findings, the researchers suggested that cardiovascular risk assessment in patients with NAFLD should take sex-related differences into account, as women with fatty liver disease may require more aggressive prevention measures -- such as weight loss, better diet, more exercise, or use of aspirin or statins -- to avoid adverse cardiovascular outcomes.



A Allen et al. Cardiovascular risk in NAFLD -- not an equal opportunity: implications for women’s health. AASLD: The Liver Meeting. Washington, DC, October 20-24, 2017. Abstract 55.